All News

From Patti Yasutake’s death from cancer to Olympic water polo player’s husband’s rare cancer diagnosis, here’s what’s happening in the oncology space this week.

An expert explained the importance of understanding different subtypes of metastatic breast cancer and available treatment options based on biomarker testing.

Through colon cancer and liver cancer, faith is what brought me to peace and clarity during treatment and now survivorship.

For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent.

When I started experiencing symptoms of an infection, I was worried that my follicular lymphoma had returned.

The cancer vaccine, mRNA-4157, garnered immune responses of 30 weeks among some patients with melanoma and lung cancer, study results showed.

Lymphir, an immunotherapy, has been approved by the FDA to treat patients with relapsed or refractory cutaneous T-cell lymphoma.

The National Comprehensive Cancer Network now recommends Rytelo for patients with myelodysplastic syndrome who require blood transfusions.

The FDA will review an application for Cabometyx as a potential treatment for pancreatic neuroendocrine tumors after findings from a phase 3 trial.

Interventions, such as speech therapy, after receiving radioactive iodine treatment for thyroid cancer may help manage quality of life.

During my chemotherapy treatments for chronic lymphocytic leukemia, I had a supportive group of people surrounding me.

The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery.

Patients with blood cancer who undergo CAR-T cell therapy should monitor for fever and signs of respiratory distress, an expert said.

Understanding how I fit in matters to me but figuring out my identity in the cancer space is not always easy.

Revised guidelines also recommend mindfulness-based programs, yoga, acupressure and more to ease cancer-related fatigue.

Patients with unresectable stage 3 non-small cell lung cancer treated with Tecentriq before and following chemoradiation may derive a survival benefit.

Certain patients with non-small cell lung cancer who are treatment-naive may benefit from receiving a biopsy regarding treatment decision-making.

I happened to see my breast surgeon at an art show and, out of respect, chose not to talk to her.

A physical therapist offers tips and exercises that can help patients with cancer who experiencing difficulty walking from either the disease or its treatments.

More often lately, I have tied these more specifically to my date of diagnosis. I just can’t get March 3 out of my thoughts. That is when I began to survive cancer.

I have watched her jump through rings of fire time and time again to advocate for her patients.

When compared with Zytiga, Xtandi appeared to have a lower incidence of infection among men with prostate cancer, especially those under 70 years.

My son has been in the battle of winning over cancer for almost 10 years and was excited to have an African American woman added to his care team.

“I take, perhaps, greater pride and have maybe a little bit of jealousy when I hear that my patients have been looking forward to seeing their nurse Tamara Carey, APRN in clinic,” an oncologist wrote.

CURE® spoke to an expert from Emory University in Atlanta about tonsil cancer, its “gold standard” treatment and potential side effects.

It was beneficial for both myself and my loved ones when I gave a concrete answer to the question of “how can I help?”

From “Top Chef’” Shirley Chung and comedian Christina Pazsitzky announcing their diagnoses to Erica Ash’s death from the disease, here is what’s happening in the oncology space this week.

Tecelra is the first cell therapy to be approved for a solid cancer in the United States, and marks the end of a decade-long drought of new drugs for this patient population.